2 active not recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Active not recruiting 2 |
Follow NAFLD: new trials by email Literature Review of NAFLD trials Research Report on NAFLD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Semaglutide vs Sitagliptin Semaglutide Treatment, Sitagliptin 100mg - Liver Transplant; Complications, Diabetes Mellitus | Phase 4 | Active not recruiting | University Health Network, Toronto | 58 | 2022-10-26 | 2026-10-14 |
| Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients Empagliflozin 10 MG, Placebo pills - Chronic Hepatitis b, NAFLD | Phase 4 | Active not recruiting | The University of Hong Kong | 106 | 2022-01-02 | 2026-01-30 |
Non-alcoholic Fatty Liver Disease (2) · Diabetes Mellitus (1) · Fibrosis (1) · Hepatitis B, Chronic (1) · Liver Cirrhosis (1)
Digestive System Diseases (2) · Fatty Liver (2) · Liver Diseases (2) · Blood-Borne Infections (1) · Chronic Disease (1) · Communicable Diseases (1) · DNA Virus Infections (1) · Disease Attributes (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Hepadnaviridae Infections (1) · Hepatitis (1) · Hepatitis B (1) · Hepatitis, Chronic (1) · Hepatitis, Viral, Human (1)
Sitagliptin Phosphate (1) · empagliflozin (1)
The University of Hong Kong (1) · University Health Network, Toronto (1)
Canada (1) · Hong Kong (1)
Ka Shing Cheung, MD, MPH (1) · Mamatha Bhat, MD (1)